Levin Capital Strategies’s Aerie Pharmaceuticals AERI Stock Holding History

Levin Capital Strategies’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-32,500	Closed	-$371K	–	444
2021 Q3	$371K	Buy	+32,500	New	+$475K	0.04%	210

Levin Capital Strategies's AERI Position: Q4 2022 in Review

Levin Capital Strategies sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,125,395 shares — an estimated $17M sold.

Levin Capital Strategies first reported a position in AERI in Q1 2019 and held it in 15 quarters. The position peaked at $40.5M in Q4 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Levin Capital Strategies reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Levin Capital Strategies sold 1,125,395 Aerie Pharmaceuticals shares in Q4 2022, an estimated $17M.
Levin Capital Strategies first reported a position in Aerie Pharmaceuticals in Q1 2019 and held it in 15 quarters.
Levin Capital Strategies's Aerie Pharmaceuticals position peaked at $40.5M in Q4 2019.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Levin Capital Strategies's 13F filing for Q4 2022, filed 13 Feb 2023.